| Sivan Sadeh, FNP-C | |
|
3451 E 12th St, Oakland, CA 94601-3463 | |
| (510) 535-3500 | |
| Not Available |
| Full Name | Sivan Sadeh |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 3451 E 12th St, Oakland, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053080309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 95018356 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| La Clinica De La Raza Inc | 1557258282 | 107 |
News Archive
Steroid therapy is associated with a considerable reduction in all-cause mortality and new-onset and progressive cardiomyopathy in patients with the debilitating X-linked disease Duchenne muscular dystrophy.
Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
New standards to help ensure the quality and enhance the safety of key ingredients widely used in infant formulas and a variety of functional foods are being proposed for inclusion in the Food Chemicals Codex (FCC), an internationally recognized compendium of quality standards for food ingredients.
› Verified 1 days ago
| Entity Name | La Clinica De La Raza Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144336181 PECOS PAC ID: 1557258282 Enrollment ID: O20040227001016 |
News Archive
Steroid therapy is associated with a considerable reduction in all-cause mortality and new-onset and progressive cardiomyopathy in patients with the debilitating X-linked disease Duchenne muscular dystrophy.
Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
New standards to help ensure the quality and enhance the safety of key ingredients widely used in infant formulas and a variety of functional foods are being proposed for inclusion in the Food Chemicals Codex (FCC), an internationally recognized compendium of quality standards for food ingredients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sivan Sadeh, FNP-C 3272 Knowland Ave, Oakland, CA 94619-2630 Ph: (323) 376-0564 | Sivan Sadeh, FNP-C 3451 E 12th St, Oakland, CA 94601-3463 Ph: (510) 535-3500 |
News Archive
Steroid therapy is associated with a considerable reduction in all-cause mortality and new-onset and progressive cardiomyopathy in patients with the debilitating X-linked disease Duchenne muscular dystrophy.
Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
New standards to help ensure the quality and enhance the safety of key ingredients widely used in infant formulas and a variety of functional foods are being proposed for inclusion in the Food Chemicals Codex (FCC), an internationally recognized compendium of quality standards for food ingredients.
› Verified 1 days ago
Emily Duane Lloyd, NPF Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1030 International Blvd, Oakland, CA 94606 Phone: 510-238-5400 Fax: 510-238-5437 | |
Erica Tringale, N.P, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 747 52nd St, Oakland, CA 94609 Phone: 510-428-3373 | |
Shelley Anne Bull, CPNP-PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 747 52nd St, Oakland, CA 94609 Phone: 510-428-3885 | |
Mrs. Michelle Annette Harris-miller, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3025 High St, Oakland, CA 94619 Phone: 510-261-5200 | |
Annie Roque, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 747 52nd St, Oakland, CA 94609 Phone: 510-428-4418 | |
Mr. Keith M. Thibault, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
Colleen Mccullough, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2950 International Blvd, Oakland, CA 94601 Phone: 510-535-4400 |